Blood Res.  2015 Mar;50(1):1-2. 10.5045/br.2015.50.1.1.

Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia

• Park R

• KMID: 1787903
• DOI: http://doi.org/10.5045/br.2015.50.1.1

Abstract

No abstract available.

MeSH Terms

Adult*
Humans
Thrombocytopenia*

Reference

1. Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood. 2005; 106:2244–2251. PMID: 15941913.

2. Saleh MN, Bussel JB, Cheng G, et al. Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study. Blood. 2013; 121:537–545. PMID: 23169778.

3. Cheng G. Eltrombopag, a thrombopoietin-receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile. Ther Adv Hematol. 2012; 3:155–164. PMID: 23556122.

4. McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood. 2004; 103:1364–1369. PMID: 14576051.

5. Li J, Yang C, Xia Y, et al. Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood. 2001; 98:3241–3248. PMID: 11719360.

6. Kuter DJ, Bussel JB, Lyons RM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008; 371:395–403. PMID: 18242413.

7. Nurden AT, Viallard JF, Nurden P. New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura. Lancet. 2009; 373:1562–1569. PMID: 19324405.

8. Bussel JB, Cheng G, Saleh MN, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med. 2007; 357:2237–2247. PMID: 18046028.

9. Kim YK, Lee SS, Jeong SH, et al. Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia. Blood Res. 2015; 50:19–25.

10. Tomiyama Y, Miyakawa Y, Okamoto S, et al. A lower starting dose of eltrombopag is efficacious in Japanese patients with previously treated chronic immune thrombocytopenia. J Thromb Haemost. 2012; 10:799–806. PMID: 22409309.